Bank Of Montreal Pacira Bio Sciences, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 39,585 shares of PCRX stock, worth $770,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,585

Previous 22,825 73.43%

Holding current value

$770,719

Previous $653,000 8.73%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $196,092 - $476,989	16,760 Added 73.43%	39,585 $596,000
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $455,991 - $563,461	17,882 Added 361.76%	22,825 $653,000
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $57,477 - $73,621	-2,075 Reduced 29.57%	4,943 $144,000
Q4 2023 Feb 08, 2024	BUY	$26.32 - $34.31 $21,977 - $28,648	835 Added 13.5%	7,018 $236,000
Q3 2023 Nov 01, 2023	BUY	$30.68 - $40.09 $19,880 - $25,978	648 Added 11.71%	6,183 $189,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $47.5 $51,037 - $67,117	1,413 Added 34.28%	5,535 $221,000
Q1 2023 Jun 13, 2024	BUY	$35.53 - $43.38 $63,314 - $77,303	1,782 Added 36.05%	6,725 $274,000
Q4 2022 Feb 01, 2023	SELL	$38.19 - $57.45 $32,155 - $48,372	-842 Reduced 16.96%	4,122 $159,000
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $13,886 - $15,959	271 Added 5.77%	4,964 $270,000
Q2 2022 Aug 11, 2022	SELL	$51.49 - $81.64 $385,608 - $611,401	-7,489 Reduced 61.48%	4,693 $272,000
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $8,164 - $10,402	136 Added 1.13%	12,182 $929,000
Q4 2021 Feb 11, 2022	SELL	$47.97 - $62.21 $151,825 - $196,894	-3,165 Reduced 20.81%	12,046 $753,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $14,206 - $15,938	-260 Reduced 1.68%	15,211 $863,000
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $915,573 - $1.08 Million	15,471 New	15,471 $964,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account